Search - tctmd.com

Displaying 261 - 279 of 279

Sort: Relevancy | Date

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Industry News

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

July 03, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

April 13, 2012

News Daily News

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Jason Kahn

March 22, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

News Industry News

Bard Acquires Lutonix, Inc.

December 19, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

November 03, 2011

News Daily News

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

Jason Kahn

September 15, 2011

News Daily News

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Jason Kahn

September 08, 2011

News Industry News

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

July 25, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Industry News

Advertisement

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Bard Acquires Lutonix, Inc.

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT

Drug-Eluting Balloon Continues to Show Positive Results in SFA, Popliteal Disease

Drug-Eluting Balloons Show ‘Impressive’ Results in Below-the-Knee Lesions

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Paclitaxel Balloon Maintains Advantage at 5 Years

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content